Antopina, Bb Girl -.

HRN: 22-41-06  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2022
AMPICILLIN 500MG (VIAL)
12/25/2022
01/01/2023
IV
140mg
Q12
PSNB, WBC 34.4
Waiting Final Action 
12/25/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
12/25/2022
01/01/2023
IV
14mg
Q24
PSNB, WBC 34.4
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: